Canaan reels in a jumbo $800M fund with a big focus on a new wave of biotech startups
In the latest sign of the leviathan appetite venture investors have for new technology, Canaan Partners — one of the busiest players in biotech — has raised …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
